Evaluation of avelumab first-line (1L) maintenance therapy and subsequent treatment (tx) in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC) using a large claims database in Japan: JAVEMACS-D.
| Publicado en: | Journal of Clinical Oncology Vol. 43; pp. 700 - 942 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Journal Article |
| Publicado: |
American Society of Clinical Oncology
2/10/2025 Supplement5
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=184084920&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 184084920 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 0732183X 20D jtl: Journal of Clinical Oncology issn: 0732183X maglogo: N pubinfo: dt: 2/10/2025 Supplement5 vid: 43 pid: 26892 pub: American Society of Clinical Oncology place: Alexandria, Virginia artinfo: ui: 184084920 10.1200/JCO.2025.43.5_suppl.700 184084920 ppf: 700 ppct: 242 formats: tig: atl: Evaluation of avelumab first-line (1L) maintenance therapy and subsequent treatment (tx) in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC) using a large claims database in Japan: JAVEMACS-D. aug: au: Kobayashi, Takashi Kitamura, Hiroshi Furukawa, Yuka Kambe, Anzu Shono, Michihiro Ito, Takayuki Kikuchi, Eiji affil: Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|